Instadose Pharma Corp (INSD)
0.00
USD |
OTCM |
May 20, 16:00
Instadose Pharma Shareholders Equity (Quarterly): 27.95M for Feb. 28, 2022
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
February 28, 2022 | 27.95M |
November 30, 2021 | -0.1623M |
August 31, 2021 | -0.1132M |
May 31, 2021 | -0.0604M |
February 28, 2021 | -0.0124M |
November 30, 2020 | -0.0824M |
August 31, 2020 | -0.0745M |
May 31, 2020 | -0.0703M |
February 29, 2020 | -0.0655M |
November 30, 2019 | -0.0567M |
Date | Value |
---|---|
August 31, 2019 | -0.0522M |
May 31, 2019 | -0.0473M |
February 28, 2019 | -0.0426M |
November 30, 2018 | -0.0334M |
August 31, 2018 | -0.03M |
May 31, 2018 | -0.0261M |
February 28, 2018 | -0.0233M |
November 30, 2017 | -0.012M |
August 31, 2017 | 0.005M |
May 31, 2017 | -0.0047M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-0.1623M
Minimum
Nov 2021
27.95M
Maximum
Feb 2022
2.263M
Average
-0.063M
Median
Shareholders Equity (Quarterly) Benchmarks
Neovasc Inc (DELISTED) | 15.84M |
InMed Pharmaceuticals Inc | 11.10M |
Tetra Bio Pharma Inc | -4.513M |
Venus Concept Inc | -22.49M |
Lucy Scientific Discovery Inc | 0.0812M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 36.01M |
Total Liabilities (Quarterly) | 8.060M |